<!DOCTYPE html>
<html lang="pt-BR">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Conhecimento Apurado - Semaglutida & Tirzepatida</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            background-color: #f3f4f6;
            line-height: 1.6;
        }
        
        .header {
            background: white;
            box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1);
            border-bottom: 1px solid #e5e7eb;
        }
        
        .header-content {
            max-width: 1280px;
            margin: 0 auto;
            padding: 0 1rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding-top: 1rem;
            padding-bottom: 1rem;
        }
        
        .logo-section {
            display: flex;
            align-items: center;
        }
        
        .logo-icon {
            width: 2rem;
            height: 2rem;
            background: #2563eb;
            border-radius: 4px;
            margin-right: 0.75rem;
            display: flex;
            align-items: center;
            justify-content: center;
            color: white;
            font-weight: bold;
        }
        
        .logo-text h1 {
            font-size: 1.5rem;
            font-weight: bold;
            color: #111827;
        }
        
        .logo-text p {
            font-size: 0.875rem;
            color: #6b7280;
        }
        
        .header-right {
            display: flex;
            align-items: center;
            gap: 1rem;
        }
        
        .search-container {
            position: relative;
        }
        
        .search-input {
            padding-left: 2.5rem;
            padding-right: 1rem;
            padding-top: 0.5rem;
            padding-bottom: 0.5rem;
            border: 1px solid #d1d5db;
            border-radius: 0.5rem;
            font-size: 0.875rem;
            width: 300px;
        }
        
        .search-input:focus {
            outline: none;
            ring: 2px;
            ring-color: #2563eb;
            border-color: transparent;
        }
        
        .search-icon {
            position: absolute;
            left: 0.75rem;
            top: 0.75rem;
            width: 1.25rem;
            height: 1.25rem;
            color: #9ca3af;
        }
        
        .update-info {
            font-size: 0.875rem;
            color: #6b7280;
        }
        
        .main-container {
            display: flex;
            min-height: calc(100vh - 80px);
        }
        
        .sidebar {
            width: 16rem;
            background: white;
            box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1);
            min-height: 100%;
        }
        
        .sidebar-content {
            padding: 1rem;
        }
        
        .nav-button {
            width: 100%;
            display: flex;
            align-items: center;
            padding: 0.75rem 1rem;
            text-align: left;
            border-radius: 0.5rem;
            transition: all 0.2s;
            border: none;
            background: none;
            cursor: pointer;
            margin-bottom: 0.5rem;
            font-size: 0.875rem;
            font-weight: 500;
        }
        
        .nav-button:hover {
            background-color: #f3f4f6;
        }
        
        .nav-button.active {
            background-color: #2563eb;
            color: white;
        }
        
        .nav-icon {
            width: 1.25rem;
            height: 1.25rem;
            margin-right: 0.75rem;
        }
        
        .content {
            flex: 1;
            padding: 1.5rem;
        }
        
        .section {
            display: none;
        }
        
        .section.active {
            display: block;
        }
        
        .section-title {
            font-size: 1.5rem;
            font-weight: bold;
            margin-bottom: 1.5rem;
            color: #111827;
        }
        
        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1rem;
            margin-bottom: 1.5rem;
        }
        
        .stat-card {
            padding: 1.5rem;
            border-radius: 0.5rem;
            color: white;
            display: flex;
            align-items: center;
            justify-content: space-between;
        }
        
        .stat-card.blue { background-color: #2563eb; }
        .stat-card.green { background-color: #059669; }
        .stat-card.purple { background-color: #7c3aed; }
        .stat-card.orange { background-color: #ea580c; }
        
        .stat-info p:first-child {
            opacity: 0.8;
            font-size: 0.875rem;
        }
        
        .stat-info p:last-child {
            font-size: 1.5rem;
            font-weight: bold;
        }
        
        .stat-icon {
            width: 2rem;
            height: 2rem;
            opacity: 0.7;
        }
        
        .card {
            background: white;
            border-radius: 0.5rem;
            box-shadow: 0 1px 3px 0 rgba(0, 0, 0, 0.1);
            padding: 1.5rem;
            margin-bottom: 1.5rem;
        }
        
        .card-title {
            font-size: 1.125rem;
            font-weight: 600;
            margin-bottom: 1rem;
            color: #111827;
            display: flex;
            align-items: center;
        }
        
        .card-icon {
            width: 1.25rem;
            height: 1.25rem;
            margin-right: 0.5rem;
        }
        
        .grid {
            display: grid;
            gap: 1.5rem;
        }
        
        .grid-2 {
            grid-template-columns: repeat(auto-fit, minmax(400px, 1fr));
        }
        
        .grid-3 {
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
        }
        
        .grid-4 {
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
        }
        
        .progress-bar {
            width: 100%;
            background-color: #e5e7eb;
            border-radius: 9999px;
            height: 0.5rem;
            margin-top: 0.25rem;
        }
        
        .progress-fill {
            height: 100%;
            border-radius: 9999px;
            transition: width 0.3s;
        }
        
        .progress-fill.blue { background-color: #2563eb; }
        .progress-fill.green { background-color: #059669; }
        .progress-fill.orange { background-color: #ea580c; }
        
        .table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 1rem;
        }
        
        .table th,
        .table td {
            border: 1px solid #e5e7eb;
            padding: 0.75rem;
            text-align: left;
        }
        
        .table th {
            background-color: #f9fafb;
            font-weight: 600;
            color: #374151;
        }
        
        .table tr:hover {
            background-color: #f9fafb;
        }
        
        .badge {
            padding: 0.25rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.75rem;
            font-weight: 500;
        }
        
        .badge.green {
            background-color: #d1fae5;
            color: #065f46;
        }
        
        .badge.blue {
            background-color: #dbeafe;
            color: #1e40af;
        }
        
        .badge.red {
            background-color: #fee2e2;
            color: #991b1b;
        }
        
        .badge.orange {
            background-color: #fed7aa;
            color: #9a3412;
        }
        
        .badge.yellow {
            background-color: #fef3c7;
            color: #92400e;
        }
        
        .badge.gray {
            background-color: #f3f4f6;
            color: #374151;
        }
        
        .drug-selector {
            margin-bottom: 1rem;
        }
        
        .drug-selector select {
            border: 1px solid #d1d5db;
            border-radius: 0.5rem;
            padding: 0.5rem 0.75rem;
            font-size: 0.875rem;
        }
        
        .section-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 1.5rem;
        }
        
        .highlight-box {
            padding: 0.75rem;
            border-radius: 0.5rem;
            margin-top: 0.5rem;
            font-size: 0.875rem;
        }
        
        .highlight-box.blue {
            background-color: #eff6ff;
            color: #1e40af;
            border-left: 4px solid #2563eb;
        }
        
        .highlight-box.green {
            background-color: #f0fdf4;
            color: #166534;
            border-left: 4px solid #16a34a;
        }
        
        .highlight-box.red {
            background-color: #fef2f2;
            color: #991b1b;
            border-left: 4px solid #dc2626;
        }
        
        .highlight-box.orange {
            background-color: #fff7ed;
            color: #9a3412;
            border-left: 4px solid #ea580c;
        }
        
        .list {
            list-style-type: disc;
            list-style-position: inside;
            color: #6b7280;
        }
        
        .list li {
            margin-bottom: 0.25rem;
        }
        
        .border-left {
            border-left: 4px solid;
            padding-left: 1rem;
        }
        
        .border-left.blue { border-left-color: #2563eb; }
        .border-left.green { border-left-color: #16a34a; }
        .border-left.purple { border-left-color: #7c3aed; }
        .border-left.red { border-left-color: #dc2626; }
        
        .alert-box {
            border: 1px solid #e5e7eb;
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }
        
        .flex {
            display: flex;
        }
        
        .items-center {
            align-items: center;
        }
        
        .items-start {
            align-items: flex-start;
        }
        
        .justify-between {
            justify-content: space-between;
        }
        
        .gap-2 {
            gap: 0.5rem;
        }
        
        .gap-4 {
            gap: 1rem;
        }
        
        .mt-2 {
            margin-top: 0.5rem;
        }
        
        .mb-2 {
            margin-bottom: 0.5rem;
        }
        
        .mb-4 {
            margin-bottom: 1rem;
        }
        
        .text-sm {
            font-size: 0.875rem;
        }
        
        .text-xs {
            font-size: 0.75rem;
        }
        
        .font-bold {
            font-weight: 700;
        }
        
        .font-semibold {
            font-weight: 600;
        }
        
        .text-gray-600 {
            color: #4b5563;
        }
        
        .text-gray-700 {
            color: #374151;
        }
        
        .text-blue-600 {
            color: #2563eb;
        }
        
        .text-green-600 {
            color: #16a34a;
        }
        
        .text-red-600 {
            color: #dc2626;
        }
        
        .bg-gray-50 {
            background-color: #f9fafb;
        }
        
        .hidden {
            display: none;
        }
        
        @media (max-width: 768px) {
            .main-container {
                flex-direction: column;
            }
            
            .sidebar {
                width: 100%;
                order: 2;
            }
            
            .content {
                order: 1;
            }
            
            .header-content {
                flex-direction: column;
                gap: 1rem;
            }
            
            .search-input {
                width: 100%;
            }
            
            .stats-grid {
                grid-template-columns: 1fr;
            }
            
            .grid-2,
            .grid-3,
            .grid-4 {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>
<body>
    <!-- Header -->
    <header class="header">
        <div class="header-content">
            <div class="logo-section">
                <div class="logo-icon">‚ö°</div>
                <div class="logo-text">
                    <h1>Conhecimento Apurado</h1>
                    <p>Sistema de Intelligence - Semaglutida & Tirzepatida</p>
                </div>
            </div>
            <div class="header-right">
                <div class="search-container">
                    <div class="search-icon">üîç</div>
                    <input type="text" class="search-input" placeholder="Buscar informa√ß√µes..." id="searchInput">
                </div>
                <div class="update-info">
                    √öltima atualiza√ß√£o: <span id="currentDate"></span>
                </div>
            </div>
        </div>
    </header>

    <div class="main-container">
        <!-- Sidebar -->
        <nav class="sidebar">
            <div class="sidebar-content">
                <button class="nav-button active" data-section="dashboard">
                    <span class="nav-icon">üìä</span>
                    Dashboard
                </button>
                <button class="nav-button" data-section="products">
                    <span class="nav-icon">üìã</span>
                    Produtos & Tratamentos
                </button>
                <button class="nav-button" data-section="clinical">
                    <span class="nav-icon">üè•</span>
                    Contexto Cl√≠nico
                </button>
                <button class="nav-button" data-section="knowledge">
                    <span class="nav-icon">üéØ</span>
                    Conhecimentos Complementares
                </button>
                <button class="nav-button" data-section="competitive">
                    <span class="nav-icon">üìà</span>
                    An√°lise Competitiva
                </button>
            </div>
        </nav>

        <!-- Main Content -->
        <main class="content">
            <!-- Dashboard Section -->
            <div id="dashboard" class="section active">
                <h2 class="section-title">Dashboard Executivo</h2>
                
                <div class="stats-grid">
                    <div class="stat-card blue">
                        <div class="stat-info">
                            <p>Market Share</p>
                            <p>90%</p>
                        </div>
                        <div class="stat-icon">üìà</div>
                    </div>
                    <div class="stat-card green">
                        <div class="stat-info">
                            <p>Pacientes Tratados</p>
                            <p>2.5M+</p>
                        </div>
                        <div class="stat-icon">üë•</div>
                    </div>
                    <div class="stat-card purple">
                        <div class="stat-info">
                            <p>Receita Mensal</p>
                            <p>R$ 1.2B</p>
                        </div>
                        <div class="stat-icon">üí∞</div>
                    </div>
                    <div class="stat-card orange">
                        <div class="stat-info">
                            <p>Efic√°cia M√©dia</p>
                            <p>18%</p>
                        </div>
                        <div class="stat-icon">‚ö°</div>
                    </div>
                </div>

                <div class="grid grid-2">
                    <div class="card">
                        <h3 class="card-title">
                            <span class="card-icon">üìä</span>
                            Compara√ß√£o de Efic√°cia
                        </h3>
                        <div style="margin-bottom: 1rem;">
                            <div class="flex justify-between text-sm mb-2">
                                <span>Tirzepatida 15mg</span>
                                <span class="font-bold">25%</span>
                            </div>
                            <div class="progress-bar">
                                <div class="progress-fill blue" style="width: 100%;"></div>
                            </div>
                        </div>
                        <div style="margin-bottom: 1rem;">
                            <div class="flex justify-between text-sm mb-2">
                                <span>Semaglutida 2.4mg</span>
                                <span class="font-bold">17%</span>
                            </div>
                            <div class="progress-bar">
                                <div class="progress-fill green" style="width: 68%;"></div>
                            </div>
                        </div>
                        <div>
                            <div class="flex justify-between text-sm mb-2">
                                <span>Liraglutida 3mg</span>
                                <span class="font-bold">8%</span>
                            </div>
                            <div class="progress-bar">
                                <div class="progress-fill orange" style="width: 32%;"></div>
                            </div>
                        </div>
                    </div>

                    <div class="card">
                        <h3 class="card-title">
                            <span class="card-icon">ü•ß</span>
                            Market Share por Fabricante
                        </h3>
                        <div style="display: flex; align-items: center; justify-content: space-between; margin-bottom: 0.75rem;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 1rem; height: 1rem; background-color: #2563eb; border-radius: 2px; margin-right: 0.75rem;"></div>
                                <span>Novo Nordisk</span>
                            </div>
                            <span class="font-semibold">65%</span>
                        </div>
                        <div style="display: flex; align-items: center; justify-content: space-between; margin-bottom: 0.75rem;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 1rem; height: 1rem; background-color: #16a34a; border-radius: 2px; margin-right: 0.75rem;"></div>
                                <span>Eli Lilly</span>
                            </div>
                            <span class="font-semibold">25%</span>
                        </div>
                        <div style="display: flex; align-items: center; justify-content: space-between; margin-bottom: 0.75rem;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 1rem; height: 1rem; background-color: #ea580c; border-radius: 2px; margin-right: 0.75rem;"></div>
                                <span>EMS</span>
                            </div>
                            <span class="font-semibold">8%</span>
                        </div>
                        <div style="display: flex; align-items: center; justify-content: space-between;">
                            <div style="display: flex; align-items: center;">
                                <div style="width: 1rem; height: 1rem; background-color: #6b7280; border-radius: 2px; margin-right: 0.75rem;"></div>
                                <span>Outros</span>
                            </div>
                            <span class="font-semibold">2%</span>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Products Section -->
            <div id="products" class="section">
                <div class="section-header">
                    <h2 class="section-title">Produtos e Tratamentos</h2>
                    <div class="drug-selector">
                        <select id="drugSelector">
                            <option value="both">Ambos</option>
                            <option value="semaglutida">Semaglutida</option>
                            <option value="tirzepatida">Tirzepatida</option>
                        </select>
                    </div>
                </div>

                <div class="grid grid-2" id="drugCards">
                    <div class="card" data-drug="semaglutida">
                        <div class="flex items-center justify-between mb-4">
                            <h3 class="text-xl font-semibold text-blue-600">Semaglutida</h3>
                            <span class="badge green">L√≠der de Mercado</span>
                        </div>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Mecanismo de A√ß√£o</h4>
                            <p class="text-gray-600">Agonista seletivo do receptor GLP-1. Aumenta secre√ß√£o de insulina dependente de glicose, reduz glucagon e retarda esvaziamento g√°strico.</p>
                        </div>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Posologia e Administra√ß√£o</h4>
                            <ul class="list text-gray-600">
                                <li>Injet√°vel: 1x/semana (0,25mg ‚Üí 2,4mg)</li>
                                <li>Oral (Rybelsus): 1x/dia (3mg ‚Üí 14mg)</li>
                                <li>Aplica√ß√£o subcut√¢nea: abdome, coxa ou bra√ßo</li>
                            </ul>
                        </div>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Indica√ß√µes Aprovadas</h4>
                            <ul class="list text-gray-600">
                                <li>Diabetes mellitus tipo 2</li>
                                <li>Obesidade (IMC ‚â•30) ou sobrepeso (IMC ‚â•27) com comorbidades</li>
                                <li>Redu√ß√£o de risco cardiovascular</li>
                            </ul>
                        </div>
                        <div>
                            <h4 class="font-semibold text-gray-700">Resultados Cl√≠nicos</h4>
                            <ul class="list text-gray-600">
                                <li>Redu√ß√£o HbA1c: at√© 1,9%</li>
                                <li>Perda de peso: 10-17% do peso corporal</li>
                                <li>Redu√ß√£o risco CV: 26% (SUSTAIN-6)</li>
                            </ul>
                        </div>
                    </div>

                    <div class="card" data-drug="tirzepatida">
                        <div class="flex items-center justify-between mb-4">
                            <h3 class="text-xl font-semibold text-green-600">Tirzepatida</h3>
                            <span class="badge blue">Mais Potente</span>
                        </div>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Mecanismo de A√ß√£o</h4>
                            <p class="text-gray-600">Agonista duplo dos receptores GLP-1 e GIP. A√ß√£o sin√©rgica potencializa controle glic√™mico e perda de peso.</p>
                        </div>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Posologia e Administra√ß√£o</h4>
                            <ul class="list text-gray-600">
                                <li>Injet√°vel: 1x/semana (2,5mg ‚Üí 15mg)</li>
                                <li>Escala√ß√£o: 2,5mg por 4 semanas, depois 5mg</li>
                                <li>Aumentos de 2,5mg a cada 4+ semanas conforme toler√¢ncia</li>
                            </ul>
                        </div>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Indica√ß√µes Aprovadas</h4>
                            <ul class="list text-gray-600">
                                <li>Diabetes mellitus tipo 2 (Brasil)</li>
                                <li>Obesidade (EUA, Europa - off-label no Brasil)</li>
                                <li>Apneia do sono + obesidade (EUA)</li>
                            </ul>
                        </div>
                        <div>
                            <h4 class="font-semibold text-gray-700">Resultados Cl√≠nicos</h4>
                            <ul class="list text-gray-600">
                                <li>Redu√ß√£o HbA1c: at√© 2,3%</li>
                                <li>Perda de peso: 15-25% do peso corporal</li>
                                <li>Superior √† semaglutida em ambos os desfechos</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <div class="card">
                    <h3 class="card-title">Protocolos M√©dicos Atuais</h3>
                    <div class="grid grid-2">
                        <div>
                            <h4 class="font-semibold text-blue-600 mb-2">Diabetes Tipo 2</h4>
                            <ol style="list-style-type: decimal; list-style-position: inside; color: #6b7280;">
                                <li>Metformina como primeira linha</li>
                                <li>Agonistas GLP-1 se HbA1c >7% ou necessidade perda peso</li>
                                <li>Tirzepatida prefer√≠vel se HbA1c >8% ou obesidade significativa</li>
                                <li>Combina√ß√£o com insulina em casos complexos</li>
                            </ol>
                        </div>
                        <div>
                            <h4 class="font-semibold text-green-600 mb-2">Obesidade</h4>
                            <ol style="list-style-type: decimal; list-style-position: inside; color: #6b7280;">
                                <li>Modifica√ß√£o estilo vida por 3-6 meses</li>
                                <li>Agonistas GLP-1 se IMC ‚â•30 ou ‚â•27 com comorbidades</li>
                                <li>Tirzepatida para casos refrat√°rios ou perda >20%</li>
                                <li>Cirurgia bari√°trica se farmacoterapia insuficiente</li>
                            </ol>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Clinical Section -->
            <div id="clinical" class="section">
                <h2 class="section-title">Contexto Cl√≠nico</h2>
                
                <div class="card">
                    <h3 class="card-title">Estudos Cl√≠nicos Pivotais</h3>
                    <div style="overflow-x: auto;">
                        <table class="table">
                            <thead>
                                <tr>
                                    <th>Estudo</th>
                                    <th>Medicamento</th>
                                    <th>Dura√ß√£o</th>
                                    <th>Pacientes</th>
                                    <th>HbA1c</th>
                                    <th>Perda de Peso</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td class="font-semibold">SURPASS-2</td>
                                    <td>Tirzepatida vs Semaglutida</td>
                                    <td>40 semanas</td>
                                    <td>1.878</td>
                                    <td>Tirzepatida superior (-2,3% vs -1,9%)</td>
                                    <td>Tirzepatida: 11,2% vs Semaglutida: 5,7%</td>
                                </tr>
                                <tr>
                                    <td class="font-semibold">SURMOUNT-1</td>
                                    <td>Tirzepatida</td>
                                    <td>72 semanas</td>
                                    <td>2.539</td>
                                    <td>-2,07%</td>
                                    <td>21,9% (dose 15mg)</td>
                                </tr>
                                <tr>
                                    <td class="font-semibold">STEP-1</td>
                                    <td>Semaglutida</td>
                                    <td>68 semanas</td>
                                    <td>1.961</td>
                                    <td>-1,5%</td>
                                    <td>14,9% (dose 2,4mg)</td>
                                </tr>
                                <tr>
                                    <td class="font-semibold">SURMOUNT-5</td>
                                    <td>Tirzepatida vs Semaglutida</td>
                                    <td>72 semanas</td>
                                    <td>700</td>
                                    <td>Compar√°vel</td>
                                    <td>Tirzepatida: 20,2% vs Semaglutida: 13,7%</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>

                <div class="grid grid-2">
                    <div class="card">
                        <h3 class="card-title">Tend√™ncias de Tratamento</h3>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Mudan√ßa de Paradigma</h4>
                            <p class="text-gray-600">Transi√ß√£o do foco exclusivo no controle glic√™mico para abordagem integrada diabetes-obesidade.</p>
                        </div>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Personaliza√ß√£o</h4>
                            <p class="text-gray-600">Escolha baseada em perfil do paciente: tirzepatida para maior perda de peso, semaglutida para controle CV.</p>
                        </div>
                        <div>
                            <h4 class="font-semibold text-gray-700">Combina√ß√µes</h4>
                            <p class="text-gray-600">Uso crescente com inibidores SGLT2 para potencializar efeitos metab√≥licos e cardiovasculares.</p>
                        </div>
                    </div>

                    <div class="card">
                        <h3 class="card-title">Particularidades Regionais</h3>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Brasil</h4>
                            <ul class="list text-gray-600">
                                <li>Alta preval√™ncia de diabetes (7,7% popula√ß√£o)</li>
                                <li>Obesidade crescente (22,8% adultos)</li>
                                <li>SUS: apenas metformina e insulina dispon√≠veis</li>
                                <li>Setor privado: acesso limitado por custo</li>
                            </ul>
                        </div>
                        <div>
                            <h4 class="font-semibold text-gray-700">Perfil do Paciente-Alvo</h4>
                            <ul class="list text-gray-600">
                                <li>Diabetes tipo 2 inadequadamente controlado</li>
                                <li>Obesidade com comorbidades</li>
                                <li>Falha em modifica√ß√µes do estilo de vida</li>
                                <li>Necessidade de perda de peso significativa</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <div class="card">
                    <h3 class="card-title">Efeitos Adversos e Contraindica√ß√µes</h3>
                    <div class="grid grid-3">
                        <div>
                            <h4 class="font-semibold text-red-600 mb-4">Efeitos Mais Comuns</h4>
                            <div class="border-left red" style="margin-bottom: 0.5rem;">
                                <div class="font-semibold text-gray-700">N√°usea</div>
                                <div class="text-sm text-gray-600">Semaglutida: 44% | Tirzepatida: 18%</div>
                            </div>
                            <div class="border-left red" style="margin-bottom: 0.5rem;">
                                <div class="font-semibold text-gray-700">V√¥mitos</div>
                                <div class="text-sm text-gray-600">Semaglutida: 24% | Tirzepatida: 18%</div>
                            </div>
                            <div class="border-left red" style="margin-bottom: 0.5rem;">
                                <div class="font-semibold text-gray-700">Diarreia</div>
                                <div class="text-sm text-gray-600">Semaglutida: 20% | Tirzepatida: 16%</div>
                            </div>
                            <div class="border-left red" style="margin-bottom: 0.5rem;">
                                <div class="font-semibold text-gray-700">Constipa√ß√£o</div>
                                <div class="text-sm text-gray-600">Semaglutida: 16% | Tirzepatida: 12%</div>
                            </div>
                            <div class="border-left red">
                                <div class="font-semibold text-gray-700">Dor abdominal</div>
                                <div class="text-sm text-gray-600">Semaglutida: 12% | Tirzepatida: 10%</div>
                            </div>
                        </div>
                        <div>
                            <h4 class="font-semibold" style="color: #ea580c; margin-bottom: 1rem;">Efeitos Graves</h4>
                            <ul style="list-style: none; padding: 0;">
                                <li class="flex items-start" style="margin-bottom: 0.5rem;">
                                    <span style="color: #ea580c; margin-right: 0.5rem;">‚ö†Ô∏è</span>
                                    <span class="text-gray-600">Pancreatite aguda</span>
                                </li>
                                <li class="flex items-start" style="margin-bottom: 0.5rem;">
                                    <span style="color: #ea580c; margin-right: 0.5rem;">‚ö†Ô∏è</span>
                                    <span class="text-gray-600">Problemas da ves√≠cula biliar</span>
                                </li>
                                <li class="flex items-start" style="margin-bottom: 0.5rem;">
                                    <span style="color: #ea580c; margin-right: 0.5rem;">‚ö†Ô∏è</span>
                                    <span class="text-gray-600">Rea√ß√µes de hipersensibilidade</span>
                                </li>
                                <li class="flex items-start" style="margin-bottom: 0.5rem;">
                                    <span style="color: #ea580c; margin-right: 0.5rem;">‚ö†Ô∏è</span>
                                    <span class="text-gray-600">Retinopatia diab√©tica</span>
                                </li>
                                <li class="flex items-start">
                                    <span style="color: #ea580c; margin-right: 0.5rem;">‚ö†Ô∏è</span>
                                    <span class="text-gray-600">Hipoglicemia (com sulfonilureias/insulina)</span>
                                </li>
                            </ul>
                        </div>
                        <div>
                            <h4 class="font-semibold text-red-600 mb-4">Contraindica√ß√µes</h4>
                            <ul style="list-style: none; padding: 0;">
                                <li class="flex items-start" style="margin-bottom: 0.5rem;">
                                    <span style="color: #dc2626; margin-right: 0.5rem;">‚ùå</span>
                                    <span class="text-gray-600">Diabetes tipo 1</span>
                                </li>
                                <li class="flex items-start" style="margin-bottom: 0.5rem;">
                                    <span style="color: #dc2626; margin-right: 0.5rem;">‚ùå</span>
                                    <span class="text-gray-600">Cetoacidose diab√©tica</span>
                                </li>
                                <li class="flex items-start" style="margin-bottom: 0.5rem;">
                                    <span style="color: #dc2626; margin-right: 0.5rem;">‚ùå</span>
                                    <span class="text-gray-600">Hist√≥ria pessoal/familiar de carcinoma medular da tireoide</span>
                                </li>
                                <li class="flex items-start" style="margin-bottom: 0.5rem;">
                                    <span style="color: #dc2626; margin-right: 0.5rem;">‚ùå</span>
                                    <span class="text-gray-600">S√≠ndrome de neoplasia end√≥crina m√∫ltipla tipo 2</span>
                                </li>
                                <li class="flex items-start" style="margin-bottom: 0.5rem;">
                                    <span style="color: #dc2626; margin-right: 0.5rem;">‚ùå</span>
                                    <span class="text-gray-600">Gravidez e amamenta√ß√£o</span>
                                </li>
                                <li class="flex items-start">
                                    <span style="color: #dc2626; margin-right: 0.5rem;">‚ùå</span>
                                    <span class="text-gray-600">Gastroparesia severa</span>
                                </li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Knowledge Section -->
            <div id="knowledge" class="section">
                <h2 class="section-title">Conhecimentos Complementares</h2>
                
                <div class="grid grid-2">
                    <div class="card">
                        <h3 class="card-title">
                            <span class="card-icon">üí∞</span>
                            Marketing Farmac√™utico
                        </h3>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Estrat√©gias de Posicionamento</h4>
                            <div class="highlight-box blue">
                                <p><strong>Semaglutida:</strong> "L√≠der comprovado com perfil cardiovascular estabelecido"</p>
                            </div>
                            <div class="highlight-box green">
                                <p><strong>Tirzepatida:</strong> "Nova gera√ß√£o - m√°xima efic√°cia em perda de peso"</p>
                            </div>
                        </div>
                        <div>
                            <h4 class="font-semibold text-gray-700">Programas de Acesso</h4>
                            <ul class="list text-gray-600">
                                <li>Novo Nordisk: Programa NovoCare (at√© 40% desconto)</li>
                                <li>Eli Lilly: Programa de Fidelidade Mounjaro</li>
                                <li>Samples gratuitas para in√≠cio de tratamento</li>
                                <li>Parcerias com seguros privados</li>
                            </ul>
                        </div>
                    </div>

                    <div class="card">
                        <h3 class="card-title">
                            <span class="card-icon">üë•</span>
                            T√©cnicas de Vendas Consultivas
                        </h3>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Identifica√ß√£o do Perfil</h4>
                            <div class="grid grid-2 gap-2 mt-2">
                                <div class="bg-gray-50" style="padding: 0.5rem; border-radius: 0.25rem;">
                                    <strong>Diabetes:</strong> HbA1c >7%, comorbidades
                                </div>
                                <div class="bg-gray-50" style="padding: 0.5rem; border-radius: 0.25rem;">
                                    <strong>Obesidade:</strong> IMC >30, tentativas pr√©vias
                                </div>
                            </div>
                        </div>
                        <div>
                            <h4 class="font-semibold text-gray-700">Argumentos Diferenciadores</h4>
                            <ul class="list text-gray-600 text-sm">
                                <li>Evid√™ncias head-to-head (SURPASS vs SUSTAIN)</li>
                                <li>Experi√™ncia do paciente (frequ√™ncia, tolerabilidade)</li>
                                <li>Resultados tang√≠veis (% perda peso, HbA1c)</li>
                                <li>Custo-efetividade a longo prazo</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <div class="card">
                    <h3 class="card-title">Insights de Mercado Recentes</h3>
                    <div class="grid grid-2 gap-4">
                        <div class="alert-box">
                            <div class="flex items-center justify-between mb-2">
                                <h4 class="font-semibold text-gray-700">Fiocruz-EMS Partnership</h4>
                                <span class="badge red">Muito Alto</span>
                            </div>
                            <p class="text-gray-600 text-sm mb-2">Acordo firmado para produ√ß√£o nacional de semaglutida e liraglutida, reduzindo depend√™ncia de importa√ß√£o</p>
                            <div class="flex items-center text-xs text-gray-500">
                                <span style="margin-right: 0.25rem;">üìÖ</span>
                                Agosto 2025
                            </div>
                        </div>
                        <div class="alert-box">
                            <div class="flex items-center justify-between mb-2">
                                <h4 class="font-semibold text-gray-700">Controle ANVISA</h4>
                                <span class="badge yellow">M√©dio</span>
                            </div>
                            <p class="text-gray-600 text-sm mb-2">Reten√ß√£o obrigat√≥ria de receitas para agonistas GLP-1 desde junho 2025</p>
                            <div class="flex items-center text-xs text-gray-500">
                                <span style="margin-right: 0.25rem;">üìÖ</span>
                                Junho 2025
                            </div>
                        </div>
                        <div class="alert-box">
                            <div class="flex items-center justify-between mb-2">
                                <h4 class="font-semibold text-gray-700">Redu√ß√£o de Pre√ßos</h4>
                                <span class="badge orange">Alto</span>
                            </div>
                            <p class="text-gray-600 text-sm mb-2">Novo Nordisk reduziu pre√ßos em 20% ap√≥s chegada do Mounjaro</p>
                            <div class="flex items-center text-xs text-gray-500">
                                <span style="margin-right: 0.25rem;">üìÖ</span>
                                Junho 2025
                            </div>
                        </div>
                        <div class="alert-box">
                            <div class="flex items-center justify-between mb-2">
                                <h4 class="font-semibold text-gray-700">Quebra de Patente</h4>
                                <span class="badge red">Muito Alto</span>
                            </div>
                            <p class="text-gray-600 text-sm mb-2">Patente da semaglutida expira em 2026, permitindo gen√©ricos</p>
                            <div class="flex items-center text-xs text-gray-500">
                                <span style="margin-right: 0.25rem;">üìÖ</span>
                                2026
                            </div>
                        </div>
                    </div>
                </div>

                <div class="grid grid-2">
                    <div class="card">
                        <h3 class="card-title">Gest√£o de Relacionamento</h3>
                        <div class="border-left blue" style="margin-bottom: 0.75rem;">
                            <h4 class="font-semibold text-gray-700">Endocrinologistas</h4>
                            <p class="text-gray-600 text-sm">Foco em dados de efic√°cia, estudos comparativos e guidelines internacionais</p>
                        </div>
                        <div class="border-left green" style="margin-bottom: 0.75rem;">
                            <h4 class="font-semibold text-gray-700">Cl√≠nicos Gerais</h4>
                            <p class="text-gray-600 text-sm">√änfase em facilidade de uso, perfil de seguran√ßa e algoritmos de tratamento</p>
                        </div>
                        <div class="border-left purple">
                            <h4 class="font-semibold text-gray-700">Cardiologistas</h4>
                            <p class="text-gray-600 text-sm">Destaque para benef√≠cios cardiovasculares e redu√ß√£o de fatores de risco</p>
                        </div>
                    </div>

                    <div class="card">
                        <h3 class="card-title">Modelos de Neg√≥cio M√©dico</h3>
                        <div style="margin-bottom: 0.75rem;">
                            <h4 class="font-semibold text-gray-700">Setor P√∫blico</h4>
                            <ul class="list text-gray-600 text-sm">
                                <li>Protocolos PCDT (Protocolos Cl√≠nicos)</li>
                                <li>Judicializa√ß√£o crescente</li>
                                <li>Parcerias p√∫blico-privadas</li>
                            </ul>
                        </div>
                        <div>
                            <h4 class="font-semibold text-gray-700">Setor Privado</h4>
                            <ul class="list text-gray-600 text-sm">
                                <li>Value-based care</li>
                                <li>Outcomes research</li>
                                <li>Medicina de precis√£o</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Competitive Section -->
            <div id="competitive" class="section">
                <h2 class="section-title">An√°lise Competitiva</h2>
                
                <div class="card">
                    <h3 class="card-title">Compara√ß√£o Direta - Principais Concorrentes</h3>
                    <div style="overflow-x: auto;">
                        <table class="table">
                            <thead>
                                <tr>
                                    <th>Medicamento</th>
                                    <th>Marca</th>
                                    <th>Fabricante</th>
                                    <th>Mecanismo</th>
                                    <th>Perda de Peso</th>
                                    <th>Pre√ßo (R$)</th>
                                    <th>Status</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr style="background-color: #eff6ff;">
                                    <td class="font-semibold">Semaglutida</td>
                                    <td>Ozempic/Wegovy</td>
                                    <td>Novo Nordisk</td>
                                    <td>GLP-1</td>
                                    <td class="font-bold text-blue-600">10-17%</td>
                                    <td>825 - 1.699</td>
                                    <td><span class="badge green">L√≠der</span></td>
                                </tr>
                                <tr style="background-color: #f0fdf4;">
                                    <td class="font-semibold">Tirzepatida</td>
                                    <td>Mounjaro</td>
                                    <td>Eli Lilly</td>
                                    <td>GLP-1/GIP</td>
                                    <td class="font-bold text-green-600">15-25%</td>
                                    <td>1.135 - 4.077</td>
                                    <td><span class="badge blue">Disruptor</span></td>
                                </tr>
                                <tr>
                                    <td>Liraglutida</td>
                                    <td>Saxenda/Victoza</td>
                                    <td>Novo Nordisk</td>
                                    <td>GLP-1</td>
                                    <td>8%</td>
                                    <td>730-1.100</td>
                                    <td><span class="badge gray">Concorrente</span></td>
                                </tr>
                                <tr>
                                    <td>Dulaglutida</td>
                                    <td>Trulicity</td>
                                    <td>Eli Lilly</td>
                                    <td>GLP-1</td>
                                    <td>3-5%</td>
                                    <td>400-600</td>
                                    <td><span class="badge gray">Concorrente</span></td>
                                </tr>
                                <tr>
                                    <td>Liraglutida</td>
                                    <td>Olire/Lirux</td>
                                    <td>EMS</td>
                                    <td>GLP-1</td>
                                    <td>8%</td>
                                    <td>760</td>
                                    <td><span class="badge gray">Concorrente</span></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>

                <div class="grid grid-2">
                    <div class="card">
                        <h3 class="card-title">Diferenciais Competitivos</h3>
                        <div class="highlight-box blue" style="margin-bottom: 1rem;">
                            <h4 class="font-semibold" style="color: #1e40af; margin-bottom: 0.5rem;">Semaglutida - Vantagens</h4>
                            <ul class="list" style="color: #2563eb;">
                                <li>Primeira no mercado - experi√™ncia cl√≠nica estabelecida</li>
                                <li>Dados cardiovasculares robustos (SUSTAIN-6, PIONEER-6)</li>
                                <li>M√∫ltiplas apresenta√ß√µes (injet√°vel + oral)</li>
                                <li>Programa de acesso consolidado</li>
                                <li>Menor custo por tratamento</li>
                            </ul>
                        </div>
                        <div class="highlight-box green">
                            <h4 class="font-semibold" style="color: #166534; margin-bottom: 0.5rem;">Tirzepatida - Vantagens</h4>
                            <ul class="list" style="color: #16a34a;">
                                <li>Superior em perda de peso (estudos head-to-head)</li>
                                <li>Mecanismo dual inovador (GLP-1 + GIP)</li>
                                <li>Menor incid√™ncia de n√°usea vs semaglutida</li>
                                <li>Resultados mais r√°pidos e sustentados</li>
                                <li>Potencial para novas indica√ß√µes (NASH, apneia)</li>
                            </ul>
                        </div>
                    </div>

                    <div class="card">
                        <h3 class="card-title">Estrat√©gias da Concorr√™ncia</h3>
                        <div style="margin-bottom: 1rem;">
                            <h4 class="font-semibold text-gray-700">Novo Nordisk</h4>
                            <ul class="list text-gray-600 text-sm">
                                <li>Redu√ß√£o de pre√ßos em 20% (resposta ao Mounjaro)</li>
                                <li>Investimento em educa√ß√£o m√©dica continuada</li>
                                <li>Expans√£o do programa NovoCare</li>
                                <li>Parceria com influenciadores e celebridades</li>
                            </ul>
                        </div>
                        <div>
                            <h4 class="font-semibold text-gray-700">Eli Lilly</h4>
                            <ul class="list text-gray-600 text-sm">
                                <li>Posicionamento premium baseado em efic√°cia</li>
                                <li>Investimento pesado em estudos comparativos</li>
                                <li>Parcerias estrat√©gicas com KOLs</li>
                                <li>Pipeline robusto (retatrutida - triplo agonista)</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <div class="card">
                    <h3 class="card-title">Pontos Fracos a Serem Explorados</h3>
                    <div class="grid grid-3">
                        <div class="border-left red">
                            <h4 class="font-semibold text-red-600">Concorrentes Diretos</h4>
                            <ul class="list text-gray-600 text-sm">
                                <li>Liraglutida: efic√°cia inferior, aplica√ß√£o di√°ria</li>
                                <li>Dulaglutida: menor perda de peso</li>
                                <li>EMS Olire: marca nova, efic√°cia limitada</li>
                            </ul>
                        </div>
                        <div class="border-left" style="border-left-color: #ea580c;">
                            <h4 class="font-semibold" style="color: #ea580c;">Barreiras de Entrada</h4>
                            <ul class="list text-gray-600 text-sm">
                                <li>Alto custo de desenvolvimento</li>
                                <li>Patentes at√© 2035 (tirzepatida)</li>
                                <li>Complexidade regulat√≥ria</li>
                                <li>Necessidade de estudos longos</li>
                            </ul>
                        </div>
                        <div class="border-left green">
                            <h4 class="font-semibold text-green-600">Oportunidades</h4>
                            <ul class="list text-gray-600 text-sm">
                                <li>Mercado sub-atendido no SUS</li>
                                <li>Crescimento da obesidade</li>
                                <li>Medicina preventiva</li>
                                <li>Telemedicina e DTC</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <div class="card">
                    <h3 class="card-title">Obje√ß√µes Comparativas e Respostas</h3>
                    <div style="margin-bottom: 1rem;">
                        <div class="alert-box">
                            <div class="flex items-start">
                                <span style="color: #dc2626; margin-right: 0.75rem; margin-top: 0.125rem;">‚ö†Ô∏è</span>
                                <div style="flex: 1;">
                                    <h4 class="font-semibold text-gray-700 mb-2">Obje√ß√£o: Tirzepatida √© muito cara comparada √† semaglutida</h4>
                                    <div class="flex items-start">
                                        <span style="color: #16a34a; margin-right: 0.75rem; margin-top: 0.125rem;">‚úÖ</span>
                                        <p class="text-gray-600 text-sm"><strong>Resposta:</strong> O custo deve ser avaliado por resultado obtido. Tirzepatida proporciona at√© 47% mais perda de peso, podendo reduzir tempo de tratamento e comorbidades associadas.</p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div style="margin-bottom: 1rem;">
                        <div class="alert-box">
                            <div class="flex items-start">
                                <span style="color: #dc2626; margin-right: 0.75rem; margin-top: 0.125rem;">‚ö†Ô∏è</span>
                                <div style="flex: 1;">
                                    <h4 class="font-semibold text-gray-700 mb-2">Obje√ß√£o: Semaglutida tem mais dados de seguran√ßa cardiovascular</h4>
                                    <div class="flex items-start">
                                        <span style="color: #16a34a; margin-right: 0.75rem; margin-top: 0.125rem;">‚úÖ</span>
                                        <p class="text-gray-600 text-sm"><strong>Resposta:</strong> Verdadeiro, mas tirzepatida demonstra perfil metab√≥lico superior com melhor controle de triglicer√≠deos, press√£o arterial e peso - fatores de risco CV importantes.</p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div>
                        <div class="alert-box">
                            <div class="flex items-start">
                                <span style="color: #dc2626; margin-right: 0.75rem; margin-top: 0.125rem;">‚ö†Ô∏è</span>
                                <div style="flex: 1;">
                                    <h4 class="font-semibold text-gray-700 mb-2">Obje√ß√£o: Liraglutida nacional (EMS) oferece custo-benef√≠cio melhor</h4>
                                    <div class="flex items-start">
                                        <span style="color: #16a34a; margin-right: 0.75rem; margin-top: 0.125rem;">‚úÖ</span>
                                        <p class="text-gray-600 text-sm"><strong>Resposta:</strong> Liraglutida requer aplica√ß√£o di√°ria vs semanal, com efic√°cia limitada (8% vs 17-25%). Compliance e resultados favorecem agonistas GLP-1 de nova gera√ß√£o.</p>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </main>
    </div>

    <script>
        // Initialize the current date
        document.getElementById('currentDate').textContent = new Date().toLocaleDateString('pt-BR');
        
        // Navigation functionality
        const navButtons = document.querySelectorAll('.nav-button');
        const sections = document.querySelectorAll('.section');
        
        navButtons.forEach(button => {
            button.addEventListener('click', () => {
                const targetSection = button.getAttribute('data-section');
                
                // Remove active class from all buttons and sections
                navButtons.forEach(btn => btn.classList.remove('active'));
                sections.forEach(section => section.classList.remove('active'));
                
                // Add active class to clicked button and corresponding section
                button.classList.add('active');
                document.getElementById(targetSection).classList.add('active');
            });
        });
        
        // Drug selector functionality
        const drugSelector = document.getElementById('drugSelector');
        const drugCards = document.querySelectorAll('[data-drug]');
        
        if (drugSelector) {
            drugSelector.addEventListener('change', (e) => {
                const selectedDrug = e.target.value;
                
                drugCards.forEach(card => {
                    const drugType = card.getAttribute('data-drug');
                    
                    if (selectedDrug === 'both' || selectedDrug === drugType) {
                        card.style.display = 'block';
                    } else {
                        card.style.display = 'none';
                    }
                });
            });
        }
        
        // Search functionality
        const searchInput = document.getElementById('searchInput');
        
        searchInput.addEventListener('input', (e) => {
            const searchTerm = e.target.value.toLowerCase();
            const allCards = document.querySelectorAll('.card');
            
            allCards.forEach(card => {
                const cardText = card.textContent.toLowerCase();
                if (cardText.includes(searchTerm) || searchTerm === '') {
                    card.style.display = 'block';
                } else {
                    card.style.display = 'none';
                }
            });
        });
        
        // Print functionality for reports
        function printReport() {
            window.print();
        }
        
        // Export functionality (basic CSV export for tables)
        function exportTableData(tableId, filename) {
            const table = document.getElementById(tableId);
            if (!table) return;
            
            const rows = table.querySelectorAll('tr');
            let csvContent = '';
            
            rows.forEach(row => {
                const cells = row.querySelectorAll('th, td');
                const rowData = Array.from(cells).map(cell => 
                    '"' + cell.textContent.replace(/"/g, '""') + '"'
                ).join(',');
                csvContent += rowData + '\n';
            });
            
            const blob = new Blob([csvContent], { type: 'text/csv' });
            const url = window.URL.createObjectURL(blob);
            const a = document.createElement('a');
            a.href = url;
            a.download = filename + '.csv';
            a.click();
            window.URL.revokeObjectURL(url);
        }
        
        // Mobile menu toggle (if needed)
        function toggleMobileMenu() {
            const sidebar = document.querySelector('.sidebar');
            const content = document.querySelector('.content');
            
            if (window.innerWidth <= 768) {
                sidebar.classList.toggle('hidden');
            }
        }
        
        // Responsive handling
        window.addEventListener('resize', () => {
            if (window.innerWidth > 768) {
                document.querySelector('.sidebar').classList.remove('hidden');
            }
        });
        
        // Smooth scroll for anchor links
        document.querySelectorAll('a[href^="#"]').forEach(anchor => {
            anchor.addEventListener('click', function (e) {
                e.preventDefault();
                const target = document.querySelector(this.getAttribute('href'));
                if (target) {
                    target.scrollIntoView({
                        behavior: 'smooth'
                    });
                }
            });
        });
        
        // Analytics tracking (placeholder for real implementation)
        function trackEvent(category, action, label) {
            console.log('Analytics Event:', category, action, label);
            // Implement your analytics tracking here
        }
        
        // Track navigation clicks
        navButtons.forEach(button => {
            button.addEventListener('click', () => {
                trackEvent('Navigation', 'Section Change', button.getAttribute('data-section'));
            });
        });
        
        // Track search usage
        searchInput.addEventListener('input', () => {
            trackEvent('Search', 'Query', searchInput.value);
        });
    </script>
</body>
</html>